Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 7 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Royal Melbourne Institute Of Technology has 7 pending office actions in Biotechnology & Pharmaceuticals. The matters span 7 distinct examiners and 6 distinct art units, showing broad distribution among examiners and a slightly more concentrated distribution among art units.
MERCIER, MELISSA S is the busiest examiner, with 1 pending matter. No examiner carries a larger listed share than that assignment, so counsel should organize review by individual matter rather than rely on a single examiner-wide strategy.
The portfolio's examiner count exceeds its art-unit count, meaning at least some examination activity is associated with the same unit across different examiners. That structure favors matter-level tracking of claim amendments, cited art, and response deadlines.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (50%) |
| §112 only | 1 (12%) |
| Multi-statute (no §101) | 3 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERCIER, MELISSA S | 1 | 72.1% | +5.8% |
| NGUYEN, CAM N | 1 | 84.8% | +12.3% |
| WORSHAM, JESSICA N | 1 | 56.6% | +56.4% |
| RONEY, CELESTE A | 1 | 63.0% | +17.4% |
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
| MARCSISIN, ELLEN JEAN | 1 | 34.6% | +49.4% |
| TOICH, SARA KATHERINE | 1 | 49.5% | +47.6% |
| PAGANO, ALEXANDER R | 1 | 78.7% | +11.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261934 | PROCESS FOR PREPARING METAL OXIDE NANOSHEETS | NGUYEN, CAM N | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18254983 | ORAL THERAPEUTIC DELIVERY | WORSHAM, JESSICA N | 43d overdue |
| 18858619 | COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | MERCIER, MELISSA S | — |
| 17757700 | SENSOR FOR DETECTING A BIOANALYTE AND A METHOD FOR THE DETECTION THEREOF | MARCSISIN, ELLEN JEAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17766446 | ACOUSTIC NEBULISER FOR DELIVERY OF ACTIVE AGENTS | TOICH, SARA KATHERINE | 88d overdue |
| 18254983 | ORAL THERAPEUTIC DELIVERY | WORSHAM, JESSICA N | 43d overdue |
| 17501742 | METAL ORGANIC FRAMEWORKS AND METHODS OF PREPARATION THEREOF | PAGANO, ALEXANDER R | 30d overdue |
| 18250942 | LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE | RONEY, CELESTE A | 20d |
| 18261934 | PROCESS FOR PREPARING METAL OXIDE NANOSHEETS | NGUYEN, CAM N | — |
| 18041238 | STIMULATING CELLULAR PRODUCTION OF EXOSOMES | SPENCE, JENNIFER SUZANNE | — |
| 17757700 | SENSOR FOR DETECTING A BIOANALYTE AND A METHOD FOR THE DETECTION THEREOF | MARCSISIN, ELLEN JEAN | — |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 1736 | 1 |
| 1612 | 1 |
| 1633 | 1 |
| 1677 | 1 |
| 3785 | 1 |
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18858619 | COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS | MERCIER, MELISSA S | 1615 | §102§112 | Non-Final OA | — | Pending | Oct 21, 2024 |
| 18261934 | PROCESS FOR PREPARING METAL OXIDE NANOSHEETS | NGUYEN, CAM N | 1736 | §103 | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18254983 | ORAL THERAPEUTIC DELIVERY | WORSHAM, JESSICA N | 1615 | §103§112 | Final Rejection | 43d overdue | Pending | May 30, 2023 |
| 18250942 | LYOTROPIC LIQUID CRYSTALLINE PHASE PARTICLE | RONEY, CELESTE A | 1612 | §103Other | Non-Final OA | 20d | Pending | Apr 27, 2023 |
| 18041238 | STIMULATING CELLULAR PRODUCTION OF EXOSOMES | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Final Rejection | — | Pending | Feb 10, 2023 |
| 17757700 | SENSOR FOR DETECTING A BIOANALYTE AND A METHOD FOR THE DETECTION THEREOF | MARCSISIN, ELLEN JEAN | 1677 | §102§103Other | Final Rejection | — | Pending | Jun 17, 2022 |
| 17766446 | ACOUSTIC NEBULISER FOR DELIVERY OF ACTIVE AGENTS | TOICH, SARA KATHERINE | 3785 | §103 | Non-Final OA | 88d overdue | Pending | Apr 04, 2022 |
| 17501742 | METAL ORGANIC FRAMEWORKS AND METHODS OF PREPARATION THEREOF | PAGANO, ALEXANDER R | 1692 | §112Other | Non-Final OA | 30d overdue | Pending | Oct 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRoyal Melbourne Institute Of Technology has 8 pending office actions as of October 2026, spread across 7 art units and 8 examiners.
Melissa S Mercier has the most, with 1 of Royal Melbourne Institute Of Technology's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
